Access cutting-edge melanoma treatment through this clinical trial at a research site in Pittsburgh. Study-provided care at no cost to qualified participants.
Access melanoma specialists in Pittsburgh at no cost
This study follows strict safety protocols and ethical guidelines
All study-related melanoma treatment provided free
The purpose of this study is to test the effects of anti-PI-1 inhibitor (TSR-042) or anti-PD-1/anti-TIM-3 combination (TSR-042 / TSR-022) in patients with operable melanoma.
Sponsor: Diwakar Davar
Check if you qualify for this melanoma clinical trial in Pittsburgh, PA
If you're searching for melanoma treatment options in Pittsburgh, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pittsburgh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.